Belite Bio has submitted marketing authorization applications for tinlarebant, an oral therapy for Stargardt Disease Type 1 (STGD1), to regulatory authorities in Singapore, the United Kingdom, and Switzerland via the Access Consortium pathway. If approved, tinlarebant would be the first treatment available for STGD1 in these countries, addressing a rare inherited retinal disease with no current approved therapies there. The submissions align with ongoing applications in the U.S. and Japan, aiming for global availability. Belite Bio's tinlarebant works by reducing harmful vitamin A-based toxins in the eye, potentially slowing vision loss in STGD1 patients.
Belite Bio's marketing authorization submissions for tinlarebant provide context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 15, 2026 03:02 WIB: out of 150 priced US health-sector stocks, 90 rose and 60 fell. Notably, SLS dropped 4.59% to USD 11.84 with 100% buy orders and zero typical hold time, contrasting with TMDX which fell 4.40% to USD 75.65 but had a typical hold time of 24 days. Meanwhile, RPRX gained 4.34% to USD 59.02 with a typical hold time of 6 days.
Lakefront Biotherapeutics has completed the sale of its preclinical CAR-T cell therapy programs to Belgium-based Armed Cell Therapeutics. The deal includes an upfront payment of €8 million, potential milestone payments up to $230 million, and a low s...
PNC Financial Services Group is set to report its Q3 2026 earnings with analysts forecasting earnings of around $4.91 per share and revenue near $6.61 billion, reflecting solid growth. The bank anticipates a 3%–3.5% rise in net interest income and 1%...
Leonardo DRS secured a 10-year prime contract under NASA's SEWP VI program, enabling federal agencies to quickly procure its defense products and services until 2036. This contract extends DRS's role as a SEWP prime contractor, supporting key militar...
Honey Badger Silver announced promising assay results from its first exploration program at the Yava Project in Nunavut, revealing high-grade silver, copper, gold, zinc, and lead samples. This marks the first systematic work at Yava in nearly two dec...
The 12th Annual Minneapolis C-Level Technology Leadership Summit will take place on October 27 at Interlachen Country Club, Edina, bringing together senior technology executives from leading Minnesota organizations like Cargill, Land O’Lakes, and Blu...
